| Identification | |
| Name: | Guanosine,7,8-dihydro-8-oxo-7-(2-propen-1-yl)- |
| Synonyms: | Guanosine,7,8-dihydro-8-oxo-7-(2-propenyl)- (9CI); 7-Allyl-8-oxoguanosine; Loxoribine;RWJ 21757 |
| CAS: | 121288-39-9 |
| Molecular Formula: | C13H17 N5 O6 |
| Molecular Weight: | 339.3 |
| InChI: | InChI=1/C13H17N5O6/c1-2-3-17-6-9(15-12(14)16-10(6)22)18(13(17)23)11-8(21)7(20)5(4-19)24-11/h2,5,7-8,11,19-21H,1,3-4H2,(H3,14,15,16,22)/t5-,7-,8-,11-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Melting Point: | 227-230 °C(lit.) |
| Flash Point: | 311.7°C |
| Boiling Point: | 591.8°Cat760mmHg |
| Density: | 1.92g/cm3 |
| Refractive index: | 1.812 |
| Biological Activity: | Toll-like receptor 7 (TLR7) agonist; induces immune cell activation and increases cytokine production. Displays antitumor and antiviral activity in various animal models. |
| Flash Point: | 311.7°C |
| Usage: | Small-molecule immunostimulants |
| Safety Data | |
 |
|
